44
Introduction to Addiction Sean Koon, MD California Academy of Family Physicians And California Society of Addiction Medicine April 14, 2005

Introduction to Chemical Dependency

Embed Size (px)

Citation preview

Page 1: Introduction to Chemical Dependency

Introduction to Addiction

Sean Koon, MDCalifornia Academy of Family Physicians

And California Society of Addiction Medicine

April 14, 2005

Page 2: Introduction to Chemical Dependency

Goals• Explain the medical model of addiction• Explain what makes some chemicals addictive

(and others not) ?• Explain what makes some people become

addicted (and others not) ?• What keeps them from stopping when “enough is

enough”?• When they do stop, why do some people relapse

“after they’ve been doing so well” ?

Page 3: Introduction to Chemical Dependency

Medical Model of Addiction• Expression of addiction (phenotype) is based on a

genetic predisposition (genotype) that is influenced by environmental factors

• Well-studied biological mechanism• Treatment compliance is similar to other chronic

medical conditions (diabetes, hypertension, asthma)

• Follows a relapsing and remitting course• Most effectively managed as a chronic disease • Both medical and behavioral interventions are

used

Page 4: Introduction to Chemical Dependency

Similarities with Other Chronic Diseases (Type II Diabetes, HTN, Asthma)

• Genetic impact is similar

• The contributions of environment and personal choice are comparable

• Medication adherence and relapse rates are similar.

• Long term maintenance treatments proven most effective. (McLellan, JAMA 2000)

Page 5: Introduction to Chemical Dependency

Genetics: Pedigree

• Monozygotic twins have higher concordance of addiction than dizygotic twins (the more genes you share, the more similar your addiction propensity)

• Men whose parents were alcoholics have an increased likelihood of alcoholism even when adopted and raised by non-alcoholic parents from birth

Page 6: Introduction to Chemical Dependency

Genetics: The Genome

• The minor (A1) allele of the TaqIA D2 dopamine receptor gene has been linked to severe alcoholism and polysubstance dependence

• A single nucleotide polymorphism in the gene encoding fatty acid amide hydrolase has been associated with increased recreational and problem use of drugs or alcohol

Page 7: Introduction to Chemical Dependency

Genetics: The Genome

• A Leu7Pro polymorphism of the neuropeptide Y gene has been correlated with increased alcohol consumption

• Single nucleotide polymorphisms of the gene encoding the mu-opioid receptor correlates with an increased likelihood of heroin abuse

• Genes that affect metabolism of drugs/alcohol/nicotine affect propensity for dependence

Page 8: Introduction to Chemical Dependency

Pathophysiology

• Why and how do people get addicted to drugs ?

• Why are some chemicals addictive and others not ?

Page 9: Introduction to Chemical Dependency

Pathophysiology

• Within our bodies we have very precise mechanisms for maintaining homeostasis (e.g. pituitary hormones, thyroid, insulin/glucagon, etc.)

• These mechanisms titrate necessary chemicals within the body to obtain this balance

Page 10: Introduction to Chemical Dependency

Pathophysiology

• If something is needed from outside of the body, systems of craving and satiation are necessary

• The urgency of the need is promoted by the intensity of the craving

At this moment are you more thirsty or hungry (or neither?)

Page 11: Introduction to Chemical Dependency

How it Works: The Reward Pathway

• Many parts of the brain work together to maintain this homeostasis

• The “mesolimbic” pathway uses reward (often a sense of well-being or pleasure) to promote life sustaining and life fulfilling behaviors (eating, drinking, sex, nurturing, etc.)

• Addiction occurs by dysregulation of this natural function

Page 12: Introduction to Chemical Dependency

MESOLIMBIC REWARD SYSTEM

Page 13: Introduction to Chemical Dependency

• So, if we all have this reward pathway, why don’t all substance users develop addiction ?

• Why are some chemicals addictive and others not ?

Page 14: Introduction to Chemical Dependency

The Reward Pathway

• Drugs of addiction are identifiable by their ability to stimulate dopamine secretion in this pathway

• Addicts are identifiable by their unique response to addictive chemicals by hypersecretion of dopamine in this brain pathway

Page 15: Introduction to Chemical Dependency

Dopamine release in the Nucleus Accumbens

Page 16: Introduction to Chemical Dependency

Cocaine Preventing Dopamine Re-Uptake in the Nucleus

Accumbens

Page 17: Introduction to Chemical Dependency

Opiate Action on the Nucleus Accumbens

Promotes Dopamine Release

Page 18: Introduction to Chemical Dependency

Cannabis Action on the Nucleus AccumbensPromotes Dopamine Release

Page 19: Introduction to Chemical Dependency
Page 20: Introduction to Chemical Dependency

How and when does a person “get addicted” ?

Page 21: Introduction to Chemical Dependency

The “Switch”

• The progression from social drinking to abuse to dependence ranges from 3-15 years in duration in susceptible persons

• Average age of the “switch” is mid- thirties, but can vary

“continued repetition of voluntary drug taking begins to change into involuntary drug taking, ...at which (point) the behavior is driven by compulsion to use the drug.” (Leshner, 2000)

Page 22: Introduction to Chemical Dependency

The “Switch”• Frequent drug use in a person with

biological predisposition alters the hedonic set-point and creates a starvation or craving response.

• The drug loses its pleasurable effects but becomes pathologically “wanted”

• Cravings may continue or even increase despite satiation or drug use

Page 23: Introduction to Chemical Dependency

Chronic Use: Hedonic Homeostatic Dysregulation

Hed

onic

Sca

le Normal Affective Responseto Drugs/Alcohol

Altered Dysregulated Set-Pointfollowing chronic drug use

(Koob, Science, 1997)

Hedonic Set Point is Altered with Chronic Drug Use

Initially use toget high…

Now use to “get normal”

“Cravings”

“Feel good”

“Feel bad”

Slide from Pating,D.

Page 24: Introduction to Chemical Dependency

So, why don’t they just stop when they start to suffer consequences ?

Page 25: Introduction to Chemical Dependency

Hedonic Homeostatic Dysregulation

• The reward pathway is intimately connected, via neural pathways, to our judgment and emotional areas (via projections to the prefrontal cortex and limbic system respectively)

• Judgment can be aligned or distorted to favor the restoration of homeostasis

• The brain begins to treat the chemical as necessary for homeostasis and thus survival

Page 26: Introduction to Chemical Dependency

Hedonic Homeostatic DysregulationThe patients are logically aware they do not “need” the drug, but survival drives tend to take precedence over logic and judgment

Continued substance use slowly takes “survival precedence” over life goals, self esteem, relationships, stability, safety, and health

Page 27: Introduction to Chemical Dependency

So how is it that drugs with completely opposite effects can

be equally addictive?

Each Substance of Abuse Has Both

Primary and Secondary Actions

Page 28: Introduction to Chemical Dependency

Action Sites of Marijuana

Page 29: Introduction to Chemical Dependency

Action Sites of Cocaine

Page 30: Introduction to Chemical Dependency

Action Sites of Opiates

Page 31: Introduction to Chemical Dependency

Substance Abuse and Moods

• Addictive substances can mimic mood disorders directly and indirectly– All addictive substances can cause anxiety and

depression indirectly via the secondary effect of life chaos

– They also mimic many psychiatric disorders directly

Page 32: Introduction to Chemical Dependency

Substance Abuse and Moods• Depression:

– alcohol, sedatives, MJ– withdrawal from

stimulants, ecstacy• Anxiety: Stimulants,

MJ (panic)– withdrawal from alcohol

or sedatives• Paranoia: MJ,

stimulants (intoxication or w/d)

•Psychosis: –stimulants, hallucinogens–alcohol or sedative withdrawal

•Bipolar d/o: stimulants•Insomnia: alcohol (midnight awakening), stimulants, occasionally (short acting) sedative withdrawal

Page 33: Introduction to Chemical Dependency

Mood Disorders

• Chicken and the Egg: “Do I drink or use because I’m depressed/anxious/bipolar or is it vice-versa ?”

• History will help delineate when this occurred – Was there evidence of a mood disorder pre-

experimentation?– Were there problems with mood during periods

of abstinence?– Do they get better or worse when you detox

them?

Page 34: Introduction to Chemical Dependency

Relapse

How can people relapse after they’ve quit for such long periods of time?

Page 35: Introduction to Chemical Dependency

Craving and Relapse

• During repeated drug use patients become biologically hypersensitized to:– The Drug of Choice– Other addictive drugs– Stimuli associated with drug use– Stress induced craving

• This hypersensitization is long-lasting due to adaptive and structural changes in the reward pathway

Page 36: Introduction to Chemical Dependency

Craving and RelapseFunctional Changes

• Long lasting changes in the functional activity of the mesocorticolimbic dopamine system, in glutamate and dopamine transmission in the nucleus accumbens

• Long lasting adaptive changes in gene expression and protein activation, especially “Fos” proteins (these occur through activation of the cAMP cascade via D1 dopamine receptors in the VTA)

Page 37: Introduction to Chemical Dependency

Craving and RelapseStructural Changes

• Changes in caliber of dopamine dendrites and cell bodies in the VTA (opioids)

• Increase in density/number of dendritic branches in Nucleus accumbens (stimulants)

• Decrease in neurofilament proteins

Page 38: Introduction to Chemical Dependency

Craving and Relapse• By these and likely other mechanisms,

the patient remains hypersensitized to the rewarding effects of the drug ANDexhibit the PRIMING and CONDITIONING effects

Page 39: Introduction to Chemical Dependency

Craving and Relapse• Priming: An introduction of even a tiny amount of

the drug can cause intense cravings and imminent relapse

• Conditioning: During substance use, patients also become hypersensitized to environment cues associated with use (associated smells, sights, location, sounds, stressors, people, etc.)

• These cues (or “triggers”) can cause dopamine release AS IF A SMALL AMOUNT OF THE DRUG WERE TAKEN

• Due to the stable biological changes, both priming and conditioning effects can persist for years

Page 40: Introduction to Chemical Dependency

The “Formula” for Addiction

• Genetic or biological predisposition• A specialized response to addictive

chemicals • Risk factors (mood disorders, life trauma,

environmental factors, drug availability)• Practice (“experimentation”)• The “Switch”: hypersensitization and

hedonic dysregulation

Page 41: Introduction to Chemical Dependency

The Crisis of Addiction• When addicts initially choose to use, they are often

unaware of their genetic propensity• Their initial experimentation is often acceptable and

typical for their subculture or society at large (or even recommended as in the case of rx meds)

• Continued use can cause severe consequences to self, others, and community, though these consequences often only occur after addiction has taken hold

• Once addiction is fully developed, the use of drugs and the behaviors that follow can become out of control

At the same time, chemically dependent persons remain completely responsible for their continued use of drugs AND the resultant behaviors

Page 42: Introduction to Chemical Dependency

Timeline of Untreated Addiction

The “Switch”

Experimentation

MaintenanceLOSS

Predisposing factors:•Genetics•Co-morbid conditions•Environment Multiple crises with brief

periods of abstinence

Page 43: Introduction to Chemical Dependency

Chemical Dependency as a Chronic Condition

Abuse Early Abstinence Sobriety Stable Maintenance

Complex outcomes in CD treatment: relapse is common, success is measured by retention in recovery, decreased morbidity, life improvement

Page 44: Introduction to Chemical Dependency

Primary Care WorkshopCalifornia Academy of Family Physicians

and California Society of Addiction Medicine

April 14, 2005